These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 25328894)
41. Pathogenic role of inflammatory cytokines in obesity: from insulin resistance to diabetes mellitus. Marette A Nestle Nutr Workshop Ser Clin Perform Programme; 2004; 9():141-153. PubMed ID: 15361684 [No Abstract] [Full Text] [Related]
42. Something new under the sun in the field of psoriasis? Lotti T Dermatol Ther; 2010; 23(2):99-100. PubMed ID: 20415815 [No Abstract] [Full Text] [Related]
43. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Winer DA; Winer S; Chng MH; Shen L; Engleman EG Cell Mol Life Sci; 2014 Mar; 71(6):1033-43. PubMed ID: 24127133 [TBL] [Abstract][Full Text] [Related]
44. The complex immunological and inflammatory network of adipose tissue in obesity. Apostolopoulos V; de Courten MP; Stojanovska L; Blatch GL; Tangalakis K; de Courten B Mol Nutr Food Res; 2016 Jan; 60(1):43-57. PubMed ID: 26331761 [TBL] [Abstract][Full Text] [Related]
45. Macrophage polarization in inflammatory diseases. Liu YC; Zou XB; Chai YF; Yao YM Int J Biol Sci; 2014; 10(5):520-9. PubMed ID: 24910531 [TBL] [Abstract][Full Text] [Related]
47. [Immunometabolism of exercise and sedentary lifestyle]. Moreno-Eutimio MA; Acosta-Altamirano G Cir Cir; 2014; 82(3):344-51. PubMed ID: 25238479 [TBL] [Abstract][Full Text] [Related]
48. Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases. Pham DV; Park PH Arch Pharm Res; 2020 Oct; 43(10):997-1016. PubMed ID: 33078304 [TBL] [Abstract][Full Text] [Related]
49. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation. Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833 [TBL] [Abstract][Full Text] [Related]
50. Skeletal muscle inflammation and insulin resistance in obesity. Wu H; Ballantyne CM J Clin Invest; 2017 Jan; 127(1):43-54. PubMed ID: 28045398 [TBL] [Abstract][Full Text] [Related]
51. Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus. Richardson VR; Smith KA; Carter AM Immunobiology; 2013 Dec; 218(12):1497-504. PubMed ID: 23816302 [TBL] [Abstract][Full Text] [Related]
52. Immunoinflammatory mediators in the pathogenesis of diabetes mellitus. Gomes BF; Accardo CM Einstein (Sao Paulo); 2019 Feb; 17(1):eRB4596. PubMed ID: 30810587 [TBL] [Abstract][Full Text] [Related]
53. Interferon tau alleviates obesity-induced adipose tissue inflammation and insulin resistance by regulating macrophage polarization. Ying W; Kanameni S; Chang CA; Nair V; Safe S; Bazer FW; Zhou B PLoS One; 2014; 9(6):e98835. PubMed ID: 24905566 [TBL] [Abstract][Full Text] [Related]
55. Connecting type 1 and type 2 diabetes through innate immunity. Odegaard JI; Chawla A Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a007724. PubMed ID: 22393536 [TBL] [Abstract][Full Text] [Related]
56. The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Mamane Y; Chung Chan C; Lavallee G; Morin N; Xu LJ; Huang J; Gordon R; Thomas W; Lamb J; Schadt EE; Kennedy BP; Mancini JA Diabetes; 2009 Sep; 58(9):2006-17. PubMed ID: 19581423 [TBL] [Abstract][Full Text] [Related]